Упрощенная HTML-версия
176
201.
Is severity of necrotizing pancreatitis increased in extended necrosis and
infected necrosis? / A. Perez [et al.] // Pancreas. – 2002. – № 3 (25). – Р. 229-
233.
202.
Johnson C.D. Persistent organ failure during the first week as a marker of
fatal outcome in acute pancreatitis / C.D. Johnson, M. Abu-Hilal // Gut. – 2004.
– № 9 (53). – Р. 1340-1344.
203.
Recombinant human activated protein C attenuates the
inflammatory response in endothelium and monocytes by modulating nuclear
factor-kappaB / D.E.
B.W.
//
– 2002. – № 5
(30). – Р. 288-293.
204.
JPN Guidelines for the management of acute pancreatitis: epidemiology,
etiology, natural history, and outcome predictors in acute pancreatitis //
M. Sekimoto [et al.] // J. Hepatobiliary Pancreat. Surg. – 2006. – № 1 (13). – Р.
10-24.
205.
Kelly J.H. The hepatix extracorporeal liver assist device in the treatment of
fulminant hepatic failure / J.H. Kelly, N.L. Sussman // ASAIO J. – 1994.– № 1
(40). – P. 83-85.
206.
Controversies in the etiologies of acute pancreatitis / A.S.
S.U.
M.A.
//
– 2010. – № 6 (11). – Р. 545-552.
207.
Kumar A. Myocardial dysfunction in septic shock: Part I. Clinical
manifestation of cardiovascular dysfunction / A. Kumar, C. Haery, J.E. Parrillo
// J. Cardiothorac. Vasc. Anesth. – 2001. – № 3 (15). – Р. 364-376.
208.
Late mortality in patients with severe acute pancreatitis / B. Gloor [et al.] //
Br. J. Surg. – 2001. – № 7 (88). – Р. 975-979.
209.
Liver lipid peroxidation and antioxidant capacity in cerulein-induced acute
pancreatitis / K. Batcioglu [et al.] // Braz. J. Med. Biol. Res. – 2009. – № 9 (42).
– Р. 776-782.
210.
Long-term recurrence and death rates after acute pancreatitis / H. Lund [et
al.] // Scand. J. Gastroenterol. – 2006. – № 2 (41). – Р. 234-238.